Vaccination With Sporozoites: Models and Correlates of Protection
- PMID: 31231377
- PMCID: PMC6560154
- DOI: 10.3389/fimmu.2019.01227
Vaccination With Sporozoites: Models and Correlates of Protection
Abstract
Despite continuous efforts, the century-old goal of eradicating malaria still remains. Multiple control interventions need to be in place simultaneously to achieve this goal. In addition to effective control measures, drug therapies and insecticides, vaccines are critical to reduce mortality and morbidity. Hence, there are numerous studies investigating various malaria vaccine candidates. Most of the malaria vaccine candidates are subunit vaccines. However, they have shown limited efficacy in Phase II and III studies. To date, only whole parasite formulations have been shown to induce sterile immunity in human. In this article, we review and discuss the recent developments in vaccination with sporozoites and the mechanisms of protection involved.
Keywords: Plasmodium falciparum; correlates; malaria; models; protection; sporozoites; vaccine.
Similar articles
-
Live attenuated pre-erythrocytic malaria vaccines.Hum Vaccin Immunother. 2014;10(10):2903-9. doi: 10.4161/21645515.2014.972764. Hum Vaccin Immunother. 2014. PMID: 25483648 Free PMC article. Review.
-
The Development of Whole Sporozoite Vaccines for Plasmodium falciparum Malaria.Front Immunol. 2018 Dec 11;9:2748. doi: 10.3389/fimmu.2018.02748. eCollection 2018. Front Immunol. 2018. PMID: 30619241 Free PMC article. Review.
-
Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine.J Exp Biol. 2003 Nov;206(Pt 21):3803-8. doi: 10.1242/jeb.00644. J Exp Biol. 2003. PMID: 14506215 Review.
-
Protective immunity against malaria liver stage after vaccination with live parasites.Parasite. 2008 Sep;15(3):379-83. doi: 10.1051/parasite/2008153379. Parasite. 2008. PMID: 18814710 Review.
-
Genetically engineered, attenuated whole-cell vaccine approaches for malaria.Hum Vaccin. 2010 Jan;6(1):107-13. doi: 10.4161/hv.6.1.9654. Epub 2010 Jan 29. Hum Vaccin. 2010. PMID: 19838068 Free PMC article. Review.
Cited by
-
Human transcriptional signature of protection after Plasmodium falciparum immunization and infectious challenge via mosquito bites.Hum Vaccin Immunother. 2023 Dec 15;19(3):2282693. doi: 10.1080/21645515.2023.2282693. Epub 2023 Nov 27. Hum Vaccin Immunother. 2023. PMID: 38010150 Free PMC article.
-
Naturally acquired IgG responses to Plasmodium falciparum do not target the conserved termini of the malaria vaccine candidate Merozoite Surface Protein 2.Front Immunol. 2024 Dec 9;15:1501700. doi: 10.3389/fimmu.2024.1501700. eCollection 2024. Front Immunol. 2024. PMID: 39717775 Free PMC article.
-
Progress in the Development of Subunit Vaccines against Malaria.Vaccines (Basel). 2020 Jul 10;8(3):373. doi: 10.3390/vaccines8030373. Vaccines (Basel). 2020. PMID: 32664421 Free PMC article. Review.
-
The effect of dosage on the protective efficacy of whole-sporozoite formulations for immunization against malaria.NPJ Vaccines. 2023 Nov 24;8(1):182. doi: 10.1038/s41541-023-00778-9. NPJ Vaccines. 2023. PMID: 37996533 Free PMC article.
-
Killing the competition: a theoretical framework for liver-stage malaria.Open Biol. 2022 Mar;12(3):210341. doi: 10.1098/rsob.210341. Epub 2022 Mar 30. Open Biol. 2022. PMID: 35350863 Free PMC article.
References
-
- WHO Malaria Fact Sheet. [online]. Available online at: http://www.who.int/mediacentre/factsheets/fs094/en/ (accessed January, 2019) (Online) (2018).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical